SwePub
Sök i LIBRIS databas

  Utökad sökning

L773:1525 0024
 

Sökning: L773:1525 0024 > A novel TARP-promot...

A novel TARP-promoter-based adenovirus against hormone-dependent and hormone-refractory prostate cancer

Cheng, Wing-Shing (författare)
Uppsala universitet,Enheten för klinisk immunologi
Kraaij, Robert (författare)
Nilsson, Berith (författare)
Uppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi
visa fler...
van der Weel, Laura (författare)
de Ridder, Corrina M.A. (författare)
Tötterman, Thomas H. (författare)
Uppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi
Essand, Magnus (författare)
Uppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi
visa färre...
 (creator_code:org_t)
Elsevier BV, 2004
2004
Engelska.
Ingår i: Molecular Therapy. - : Elsevier BV. - 1525-0016 .- 1525-0024. ; 10:2, s. 355-364
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • TARP (T cell receptor gamma-chain alternate reading frame protein) is a protein that in males is uniquely expressed in prostate epithelial cells and prostate cancer cells. We have previously shown that the transcriptional activity of a chimeric sequence comprising the TARP promoter (TARPp) and the PSA enhancer (PSAe) is strictly controlled by testosterone and highly restricted to cells of prostate origin. Here we report that a chimeric sequence comprising TARPp and the PSMA enhancer (PSMAe) is highly active in testosterone-deprived prostate cancer cells, while a regulatory sequence comprising PSAe, PSMAe, and TARPp (PPT) has high prostate-specific activity both in the presence and in the absence of testosterone. Therefore, the PPT sequence may, in a gene therapy setting, be beneficial to prostate cancer patients that have been treated with androgen withdrawal. A recombinant adenovirus vector with the PPT sequence, shielded from interfering adenoviral sequences by the mouse H19 insulator, yields high and prostate-specific transgene expression both in cell cultures and when prostate cancer, PC-346C, tumors were grown orthotopically in nude mice. Intravenous virus administration reveals both higher activity and higher selectivity for the insulator-shielded PPT sequence than for the immediate-early CMV promoter. Therefore, we believe that an adenovirus with therapeutic gene expression controlled by an insulator-shielded PPT sequence is a promising candidate for gene therapy of prostate cancer.

Nyckelord

Adenoviridae/*genetics
Animals
Cell Line; Tumor
Enhancer Elements (Genetics)/genetics
Gene Expression Regulation; Neoplastic
Gene Therapy/*methods
Genes; Reporter/genetics
Genetic Vectors/genetics
Humans
Insulator Elements/genetics
Luciferases/analysis/genetics
Male
Mice
Neoplasms; Hormone-Dependent/genetics/*metabolism/therapy
Nuclear Proteins/*genetics
Promoter Regions (Genetics)/*genetics
Prostatic Neoplasms/genetics/*metabolism/therapy
Research Support; Non-U.S. Gov't
Testosterone/metabolism
MEDICINE
MEDICIN

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy